Explore jobs
Find specific jobs
Explore careers
Explore professions
Best companies
Explore companies
Gilead Sciences revenue
Gilead Sciences's revenue is $28.8 billion.
What is Gilead Sciences's revenue?
- Gilead Sciences's revenue growth from 2000 to 2024 is 14,603.79%.
- Gilead Sciences has 11,800 employees, and the revenue per employee ratio is $2,436,779.
- Gilead Sciences's peak quarterly revenue was $8.5B in 2015(q4).
- Gilead Sciences peak revenue was $32.6B in 2015.
- Gilead Sciences annual revenue for 2023 was 27.1B, -0.6% growth from 2022.
- Gilead Sciences annual revenue for 2024 was 28.8B, 6.04% growth from 2023.
On this page
Zippi applies for you, and finds you a job.
Gilead Sciences historical revenue
Gilead Sciences's peak revenue was $32.6B in 2015. The peak quarterly revenue was $8.5B in 2015(q4).
Gilead Sciences's revenue increased from $195.6m in 2000 to $28.8B currently. That's a 14,603.79% change in annual revenue.
Gilead Sciences annual revenue
Gilead Sciences annual revenue over time
| Fiscal year / year | Gilead Sciences revenue |
|---|---|
| 2009 | $7.0B |
| 2010 | $7.9B |
| 2011 | $8.4B |
| 2012 | $9.7B |
| 2013 | $11.2B |
| 2014 | $24.9B |
| 2015 | $32.6B |
| 2016 | $30.4B |
| 2017 | $26.1B |
| 2018 | $22.1B |
| 2019 | $22.4B |
| 2020 | $24.7B |
| 2021 | $27.3B |
| 2022 | $27.3B |
| 2023 | $27.1B |
| 2024 | $28.8B |
How accurately did Gilead Sciences' revenue projections match actual performance?
Gilead Sciences annual growth
Gilead Sciences saw the greatest revenue growth in 2014, when revenue increased by 122.19%.
Gilead Sciences had the lowest revenue growth in 2018, when revenue changed by -15.24%.
Gilead Sciences annual growth rate over time
| Year | Gilead Sciences growth |
|---|---|
| 2009 | 31%↑ |
| 2010 | 13%↑ |
| 2011 | 5%↑ |
| 2012 | 16%↑ |
| 2013 | 15%↑ |
| 2014 | 122%↑ |
| 2015 | 31%↑ |
| 2016 | -7%↓ |
| 2017 | -14%↓ |
| 2018 | -15%↓ |
| 2019 | 1%↑ |
| 2020 | 10%↑ |
| 2021 | 11%↑ |
| 2022 | -0%↓ |
| 2023 | -1%↓ |
| 2024 | 6%↑ |
Gilead Sciences quarterly revenue over time
- Q1
- Q2
- Q3
- Q4
Gilead Sciences quarterly growth rate over time
| Year | Q1 | Q2 | Q3 | Q4 |
|---|---|---|---|---|
| 2009 | $1.5B | $1.6B | $1.8B | $2.0B |
| 2010 | $2.1B | $1.9B | $1.9B | $2.0B |
| 2011 | $1.9B | $2.1B | $2.1B | $2.2B |
| 2012 | $2.3B | $2.4B | $2.4B | $2.6B |
| 2013 | $2.5B | $2.8B | $2.8B | $3.1B |
| 2014 | $5.0B | $6.5B | $6.0B | $7.3B |
| 2015 | $7.6B | $8.2B | $8.3B | $8.5B |
| 2016 | $7.8B | $7.8B | $7.5B | $7.3B |
| 2017 | $6.5B | $7.1B | $6.5B | $5.9B |
| 2018 | $5.1B | $5.6B | $5.6B | $5.8B |
| 2019 | $5.3B | $5.7B | $5.6B | $5.9B |
| 2020 | $5.5B | $5.1B | $6.6B | $7.4B |
| 2021 | $6.4B | $6.2B | $7.4B | $7.2B |
| 2022 | $6.6B | $6.3B | $7.0B | $7.4B |
| 2023 | $6.4B | $6.6B | $7.1B | $7.1B |
| 2024 | $6.7B | $7.0B | $7.5B | $7.6B |
Gilead Sciences jobs nearby
Do you work at Gilead Sciences?
Did Gilead Sciences meet its revenue projections?
Gilead Sciences financial information
| CEO | Daniel O’Day |
| Industry | Pharmaceuticals, Biotechnology & Life Sciences |
| Company Type | Public |
| Employees Number | 11,800 |
| Date Founded | 1987 |
| Headquarters | Foster City, California |
| Number of Locations | 15 |
| Revenue | $28.8B |
| Net Income | $4,592,000,000 |
| Gross Proft | $22.5B (2024) |
| PE Ratio | 188.79 |
| Tax Rate | 0.3% |
| Market Capitalization | $90.6B |
| Total Assets | $63,171,000,000 |
| Ticker | GILD |
Gilead Sciences jobs you might like
Gilead Sciences competitors
Gilead Sciences's top competitor, Johnson & Johnson, earned an annual revenue of $88.8B.
Gilead Sciences's smallest competitor is Genentech with revenue of $166.9M last year.
| Company name | Average salary | Revenue | Employee size | Job openings |
|---|---|---|---|---|
| Johnson & Johnson | $76,686 | $88.8B | 134,500 | 2,301 |
| Amgen | $93,349 | $33.4B | 22,000 | 797 |
| Merck | $90,328 | $64.2B | 74,000 | 1,396 |
| Vertex Pharmaceuticals | $95,952 | $11.0B | 3,400 | 197 |
| Hospira | $64,435 | $4.5B | 19,000 | - |
| Abbott | $73,973 | $42.0B | 109,000 | 1,935 |
| Genentech | $97,473 | $166.9M | 13,638 | 493 |
| Bristol-Myers Squibb | $101,824 | $48.3B | 30,000 | 1,095 |
| Biogen | $92,036 | $9.7B | 9,100 | 110 |
| Leidos | $73,808 | $4.7B | 42,000 | 5,575 |
Search for jobs
Related company revenues
Working at related companies
Related company jobs
Gilead Sciences highest paying jobs
Zippia gives an in-depth look into the details of Gilead Sciences, including salaries, political affiliations, employee data, and more, in order to inform job seekers about Gilead Sciences. The employee data is based on information from people who have self-reported their past or current employments at Gilead Sciences. The data on this page is also based on data sources collected from public and open data sources on the Internet and other locations, as well as proprietary data we licensed from other companies. Sources of data may include, but are not limited to, the BLS, company filings, estimates based on those filings, H1B filings, and other public and private datasets. While we have made attempts to ensure that the information displayed are correct, Zippia is not responsible for any errors or omissions or for the results obtained from the use of this information. None of the information on this page has been provided or approved by Gilead Sciences. The data presented on this page does not represent the view of Gilead Sciences and its employees or that of Zippia.
Gilead Sciences may also be known as or be related to Gilead Sciences, Gilead Sciences Foundation, Gilead Sciences Inc and Gilead Sciences, Inc.